Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Nyberg

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Atherosclerosis|October 31, 2020
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?Günaj Rakipovski, Bidda Rolin, Natasha Barascuk, et al.
Journal of Medicinal Chemistry|December 11, 2025
A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection FractionAnne Louise Bank Kodal, Jakob Ewald, Christian Poulsen, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Atherosclerosis|October 31, 2020
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?Günaj Rakipovski, Bidda Rolin, Natasha Barascuk, et al.
Journal of Medicinal Chemistry|December 11, 2025
A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection FractionAnne Louise Bank Kodal, Jakob Ewald, Christian Poulsen, et al.
Pageof 8